Retapamulin
- Level
- Commodity
- Parent
- 51284700
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51284706This classification denotes an antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4MG6O8991R. European Medicines Agency schedules Retapamulin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25391. Retapamulin generally arises in the molecular formula C30H47NO4S. The term RETAPAMULIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19, no. 1, 2005, list 53.) Most nations schedule retapamulin under HS 29419000 and SITC 54139. As of Q4 2014, RETAPAMULIN remains the US FDA Preferred Term for this commodity. Retapamulin bears US NLM identifiers UMLS ID C1703334 and NCI Concept Code C61924. SMILES: S(C1CC2N(C(C1)CC2)C)CC(=O)OC1C2(C3C(C(C(O)C(C1)(C)C=C)C)(CCC2C)CCC3=O)C.
Same parent
Under 51284700 · 15Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.